Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal midazolam versus different doses of intranasal ketamine for reducing preoperative pediatric anxiety
IRCT201104236254N1Phase 3Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of midazolam and ketamine in preoperative anxiety and Behavioral and emotional disorders with onset in childhood and adolescence (3 arms), sponsored by Qazvin University of Medical Sciences. Primary endpoint: Reduction in preoperative pediatric anxiety. Started May 2010; status: completed.
02
Drugs
midazolamketamine
03
Conditions
preoperative anxietyBehavioral and emotional disorders with onset in childhood and adolescence
Beyond the preview
Go deeper on IRCT201104236254N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201104236254N1.